Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$98.98 - $115.74 $663,858 - $776,268
-6,707 Reduced 8.01%
77,078 $8.92 Million
Q2 2023

Aug 11, 2023

BUY
$96.34 - $112.38 $2.11 Million - $2.46 Million
21,919 Added 35.43%
83,785 $8.62 Million
Q1 2023

May 11, 2023

SELL
$107.32 - $113.5 $2.26 Million - $2.39 Million
-21,019 Reduced 25.36%
61,866 $6.75 Million
Q4 2022

Feb 13, 2023

SELL
$62.39 - $113.8 $1.37 Million - $2.5 Million
-22,000 Reduced 20.98%
82,885 $9.43 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $3.54 Million - $5.09 Million
60,154 Added 134.48%
104,885 $6.49 Million
Q2 2022

Aug 12, 2022

SELL
$79.4 - $116.36 $661,640 - $969,627
-8,333 Reduced 15.7%
44,731 $3.57 Million
Q1 2022

May 13, 2022

BUY
$86.42 - $109.81 $56,173 - $71,376
650 Added 1.24%
53,064 $5.58 Million
Q4 2021

Feb 10, 2022

BUY
$98.56 - $119.91 $2.32 Million - $2.82 Million
23,496 Added 81.25%
52,414 $5.65 Million
Q3 2021

Nov 10, 2021

BUY
$91.91 - $110.37 $87,865 - $105,513
956 Added 3.42%
28,918 $3.17 Million
Q2 2021

Aug 10, 2021

BUY
$86.24 - $95.92 $2.05 Million - $2.28 Million
23,794 Added 570.87%
27,962 $2.62 Million
Q1 2021

May 10, 2021

SELL
$71.83 - $95.48 $160,252 - $213,015
-2,231 Reduced 34.86%
4,168 $384,000
Q4 2020

Feb 10, 2021

BUY
$67.0 - $84.39 $68,943 - $86,837
1,029 Added 19.16%
6,399 $468,000
Q3 2020

Nov 13, 2020

SELL
$55.23 - $79.93 $61,691 - $89,281
-1,117 Reduced 17.22%
5,370 $417,000
Q2 2020

Aug 07, 2020

BUY
$30.2 - $56.98 $195,907 - $369,629
6,487 New
6,487 $361,000
Q1 2020

May 15, 2020

SELL
$24.87 - $38.56 $301,026 - $466,730
-12,104 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$25.43 - $36.67 $179,840 - $259,330
-7,072 Reduced 36.88%
12,104 $438,000
Q3 2019

Nov 14, 2019

BUY
$23.0 - $27.97 $193,039 - $234,752
8,393 Added 77.84%
19,176 $522,000
Q2 2019

Aug 09, 2019

BUY
$22.81 - $28.48 $245,960 - $307,099
10,783 New
10,783 $259,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.